Get the latest tech news
23andMe’s future prompts more worries, as genomic data analysis improves
The roughly 15 million customers of genetic data outfit 23andMe may be at greater risk than they realize, suggests a new New York Times story that argues
The roughly 15 million customers of genetic data outfit 23andMe may be at greater risk than they realize, suggests a new New York Times story that argues the company’s near-term woes could become problematic for others for a very long time if it can’t continue as a going concern. Certainly, with each passing day, the hope of founder and CEO Anne Wojcicki to take it private again seems more like fantasy. As a Yale biomedical professor observes to the Times, a hacked credit card can be replaced; a genome cannot.
Or read this on TechCrunch
